Recent Updates — ACH
The New York Stock Exchange notified Accendra Health that it failed to meet the continued listing standard requiring an average market capitalization of at least $50.0 million over 30 consecutive trading days and stockholders' equity of not less than $50.0 million. The notice does not trigger immediate delisting, but requires the company to submit a business plan within 45 calendar days demonstrating how it intends to regain compliance within 18 months. If accepted, the company will be subject to quarterly monitoring by the exchange. Accendra Health operates in the home healthcare sector, providing products and services for chronic conditions.
The New York Stock Exchange notified Accendra Health that its common stock failed to meet the continued listing standard because the average closing price was less than $1.00 per share over a consecutive 30-trading-day period. The company has six months to regain compliance and intends to consider alternatives, including a potential reverse stock split subject to shareholder approval at the next annual meeting in May 2027. Accendra Health operates as a provider of products, technology, and services supporting home-based care for patients with chronic conditions.
Accendra Health announced the appointment of Kenneth Gardner-Smith as its next President and Chief Executive Officer, with an effective start date of October 5, 2026. Outgoing CEO Edward A. Pesicka will remain in his role until that date and subsequently retire from the Board of Directors. The company entered into a consulting agreement with Mr. Pesicka on September 28, 2026, under which he will serve as an advisor for up to thirty months to ensure a smooth transition. His previously awarded outstanding equity awards will remain outstanding and continue to vest according to existing terms during the consulting period, and he will receive COBRA benefits. Accendra Health operates in the healthcare sector, providing health information technology solutions.
Accendra Health announced the appointment of Kenneth Gardner-Smith as its next President and Chief Executive Officer, succeeding Edward A. Pesicka who is retiring. Gardner-Smith, a current board member since March 2022, will assume the role early in the fourth quarter of 2026. His compensation package includes a $1 million annual base salary, a target bonus of 130% of base, and equity awards with a fair value of $6 million split between restricted stock units and performance share units. He also receives a $650,000 sign-on bonus and a $2 million inducement grant of cash-settled stock appreciation rights. Additionally, Scott Lloyd was named Chief Commercial Officer effective October 5, 2026, to consolidate commercial strategy and sales leadership. Accendra Health operates in the home-based healthcare sector, providing products and services for chronic conditions through brands like Apria and Byram.
Accendra Health announced it will not implement an at-the-market equity issuance program intended to reduce indebtedness, citing current market conditions and sufficient liquidity from its undrawn $300 million revolving credit facility. The company confirmed the closure of one non-core asset sale in Q3 and expects a second to close by year-end, generating approximately $45 million in cash with de minimis impact on Adjusted EBITDA. Additionally, the Board plans to announce a new CEO successor by mid-September 2026, ahead of outgoing CEO Mr. Pesicka's planned retirement at the end of the year. Accendra Health is a provider of home-based care products and services for chronic conditions.
Accendra Health declared a dividend of one preferred share purchase right for each outstanding common share to preserve net operating losses and other tax attributes under a Section 382 Rights Agreement dated August 10, 2026. The record date is August 20, 2026, with rights attaching to common stock certificates until distribution or triggering events occur. Each right entitles the holder to purchase one-thousandth of a Series C Cumulative Preferred Share at $15.00 per unit, subject to adjustment upon an ownership change where any person acquires beneficial ownership of 4.9% or more of outstanding shares. The plan expires on August 10, 2029, unless terminated earlier by the Board. Accendra Health operates in the healthcare sector, providing products and services for home-based care.